Clinical Trials Browser

Phase 3 × Breast Neoplasms × Neoadjuvant Therapy × Clear all

NCT02089100 2024-08-15

STEREO-SEIN

Phase 3 Recruiting

Breast Neoplasms

NCT03417622 2021-02-25

Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy

Phase 3 Recruiting

Margins of Excision, Breast Neoplasms

NCT02532400 2020-03-11

COMPETE

Phase 3 Terminated

Breast Neoplasms

NCT01099436 2020-01-21

NEO-ZOTAC

Phase 3 Completed

Breast Neoplasms

NCT01104571 2018-09-17

EPHOS-B

Phase 3 Unknown

Breast Neoplasms

NCT00017095 2013-10-24

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

Phase 3 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00288002 2013-08-26

Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

Phase 3 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms

NCT00070278 2013-08-07

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

Phase 3 Unknown

Breast Neoplasms

NCT00427245 2013-08-07

Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer

Phase 3 Completed

Breast Neoplasms, Infertility

NCT00002696 2013-08-02

Combination Chemotherapy in Treating Women With Stage III Breast Cancer

Phase 3 Suspended

Breast Neoplasms

NCT00072020 2013-08-02

Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast Cancer

Phase 3 Unknown

Breast Neoplasms, Neoplasm Metastasis